Honeybee venom and melittin suppress growth in breast cancer (2020)
Research has shown that honeybee venom and its main component, melittin, can effectively suppress the growth of certain breast cancer subtypes. Specifically, these substances induce cell death in triple-negative and HER2-enriched breast cancers by inhibiting the activation of key growth factor receptors. This study highlights the potential of honeybee venom as a therapeutic agent in cancer treatment.
- ▪Honeybee venom and melittin induce cell death in aggressive breast cancer subtypes.
- ▪The venom suppresses activation of EGFR and HER2 receptors.
- ▪The study suggests potential therapeutic applications of honeybee venom in cancer treatment.
Hacker News (Newest) files mainly under programming. We currently carry 5,306 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | PubMed |
| Canonical URL | https://pubmed.ncbi.nlm.nih.gov/32923684/ |
| Publication time | Wed, 20 May 2026 09:48:18 +0000 |
| Retrieval time | 2026-05-20T10:05:02.059Z |
| Last seen | 2026-05-20T10:05:02.059Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | aMiS25dfGA73 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
NPJ Precis Oncol Actions Search in PubMed Search in NLM Catalog Add to Search . 2020 Sep 1:4:24. doi: 10.1038/s41698-020-00129-0. eCollection 2020. Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer Ciara Duffy 1 2 3 4 , Anabel Sorolla 2 4 , Edina Wang 2 4 , Emily Golden 2 4 , Eleanor Woodward 2 4 , Kathleen Davern 4 5 , Diwei Ho 6 , Elizabeth Johnstone 4 7 8 , Kevin Pfleger 4 7 8 9 , Andrew Redfern 10 , K Swaminathan Iyer 5 , Boris Baer 11 , Pilar Blancafort 1 2 4 12 Affiliations Expand Affiliations 1 School of Human Sciences, The University of Western Australia, Perth, WA 6009 Australia. 2 Cancer Epigenetics Group, Harry Perkins Institute of Medical Research, Perth, WA 6009 Australia.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at PubMed.
Discussion
0 commentsMore from PubMed
